In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
  • Select events

    Select Select events(s)

  • Year

    Select Year(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic
  • Select events
  • sub-topic
  • Year
  • Resource type
  • Topic

220 results for your search

Devices.

Event : Heart Failure 2021

  • Session : Do we improve quality of life in patients with heart failure?
  • Speaker : S Anker (Berlin,DE)

Voice recognition for lung water.

Event : Heart Failure 2021

  • Session : Rapid parade of devices: emerging treatment options in heart failure, Part 2
  • Speaker : S Anker (Berlin,DE)

Dipeptidyl peptidase-3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure

Event : Heart Failure 2021

  • Session : Acute Heart Failure - Diagnostic and Clinic
  • Speaker : E Boorsma (Groningen,NL)

Advanced cancer in heart failure pts: a new concept and its consequences.

Event : Heart Failure 2021

  • Session : Preventing heart failure in cancer patients
  • Speaker : M Anker (Berlin,DE)

Welcome and introduction.

Event : Heart Failure 2021

  • Session : Improving cardiovascular and renal outcomes in diabetic kidney disease
  • Speaker : S Anker (Berlin,DE)
  • Sponsored by Sciarc GmbH

Conclusion.

Event : Heart Failure 2021

  • Session : SGLT2 inhibition in heart failure: what have we learned so far?
  • Speaker : S Anker (Berlin,DE)
  • Sponsored by Charité Berlin - Supported by an unrestricted educational grant from The Boehringer Ingelheim and Lilly Alliance

Discussion and closure.

Event : Heart Failure 2021

  • Session : Improving cardiovascular and renal outcomes in diabetic kidney disease
  • Sponsored by Sciarc GmbH

Optimizing SGLT2 inhibition: recent data.

Event : Heart Failure 2021

  • Session : Unleashing the full potential of SGLT2 inhibition in heart failure: optimizing patient benefit in clinical practice
  • Speaker : S Anker (Berlin,DE), A Coats (Warwickshire,GB)
  • Sponsored by Charité Berlin - Supported by an unrestricted educational grant from Boehringer Ingelheim

Live Q&A.

Event : Heart Failure 2021

  • Session : Unleashing the full potential of SGLT2 inhibition in heart failure: optimizing patient benefit in clinical practice
  • Sponsored by Charité Berlin - Supported by an unrestricted educational grant from Boehringer Ingelheim

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are